{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:58:27Z","timestamp":1792799907024,"version":"4.5.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-026-04328-0","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T09:57:07Z","timestamp":1775123827000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Immune-inflammatory indices as predictors of pathologic complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a systematic review and meta-analysis of observational studies"],"prefix":"10.1186","volume":"24","author":[{"given":"Mohammadsadra","family":"Shamohammadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasaman","family":"Gholinezhad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fereshte","family":"Abdolvand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armaghan","family":"Abbasi Garavand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Hamzeh","family":"Mousavie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mansour","family":"Bahardoust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Yiasemidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,2]]},"reference":[{"issue":"3","key":"4328_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"9","key":"4328_CR2","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.5306\/wjco.v15.i9.1136","volume":"15","author":"H Fadlallah","year":"2024","unstructured":"Fadlallah H, El Masri J, Fakhereddine H, Youssef J, Chemaly C, Doughan S, Abou-Kheir W. Colorectal cancer: Recent advances in management and treatment. World J Clin Oncol. 2024;15(9):1136\u201356.","journal-title":"World J Clin Oncol"},{"issue":"2","key":"4328_CR3","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1097\/DCR.0000000000003477","volume":"68","author":"MK Collard","year":"2025","unstructured":"Collard MK, Mineur L, Nekrouf C, Denost Q, Rouanet P, de Chaisemartin C, Merdrignac A, Jafari M, Cotte E, Desrame J, et al. Final Results of the GRECCAR-6 Trial on Waiting Period Following Neoadjuvant Radiochemotherapy for Locally Advanced Rectal Cancer: 5 Years of Follow-up. Dis Colon Rectum. 2025;68(2):199\u2013208.","journal-title":"Dis Colon Rectum"},{"issue":"9","key":"4328_CR4","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.annonc.2025.05.528","volume":"36","author":"RD Hofheinz","year":"2025","unstructured":"Hofheinz RD, Fokas E, Benhaim L, Price TJ, Arnold D, Beets-Tan R, Guren MG, Hospers GAP, Lonardi S, Nagtegaal ID, et al. Localised rectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2025;36(9):1007\u201324.","journal-title":"Ann Oncol"},{"issue":"28","key":"4328_CR5","doi-asserted-by":"publisher","first-page":"3355","DOI":"10.1200\/JCO.24.01160","volume":"42","author":"AJ Scott","year":"2024","unstructured":"Scott AJ, Kennedy EB, Berlin J, Brown G, Chalabi M, Cho MT, Cusnir M, Dorth J, George M, Kachnic LA, et al. Management of Locally Advanced Rectal Cancer: ASCO Guideline. J Clin Oncol. 2024;42(28):3355\u201375.","journal-title":"J Clin Oncol"},{"issue":"5","key":"4328_CR6","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/S1470-2045(21)00079-6","volume":"22","author":"T Conroy","year":"2021","unstructured":"Conroy T, Bosset JF, Etienne PL, Rio E, Fran\u00e7ois \u00c9, Mesgouez-Nebout N, Vendrely V, Artignan X, Bouch\u00e9 O, Gargot D, et al. Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol. 2021;22(5):702\u201315.","journal-title":"Lancet Oncol"},{"issue":"2","key":"4328_CR7","doi-asserted-by":"publisher","first-page":"411","DOI":"10.47162\/RJME.62.2.07","volume":"62","author":"ST Alexandrescu","year":"2021","unstructured":"Alexandrescu ST, Dumitru AV, Babiuc RD, Costea RV. Assessment of clinical and pathological complete response after neoadjuvant chemoradiotherapy in rectal adenocarcinoma and its therapeutic implications. Rom J Morphol Embryol. 2021;62(2):411\u201325.","journal-title":"Rom J Morphol Embryol"},{"key":"4328_CR8","doi-asserted-by":"publisher","first-page":"1573819","DOI":"10.3389\/fonc.2025.1573819","volume":"15","author":"L Cadili","year":"2025","unstructured":"Cadili L, Loree JM, Peacock M, DeVries K, Ghuman A, Karimuddin AA, Phang PT, Raval MJ, Brown CJ. Pathologic complete response after neoadjuvant therapy for locally advanced rectal cancer in a real-world setting: a population-based study. Front Oncol. 2025;15:1573819.","journal-title":"Front Oncol"},{"issue":"23","key":"4328_CR9","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.1200\/JCO.22.00032","volume":"40","author":"J Garcia-Aguilar","year":"2022","unstructured":"Garcia-Aguilar J, Patil S, Gollub MJ, Kim JK, Yuval JB, Thompson HM, Verheij FS, Omer DM, Lee M, Dunne RF, et al. Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy. J Clin Oncol. 2022;40(23):2546\u201356.","journal-title":"J Clin Oncol"},{"key":"4328_CR10","doi-asserted-by":"publisher","first-page":"153303382312028","DOI":"10.1177\/15330338231202893","volume":"22","author":"S Qing","year":"2023","unstructured":"Qing S, Gu L, Du T, Yin X, Zhang KJ, Zhang HJ. A Predictive Model to Evaluate Pathologic Complete Response in Rectal Adenocarcinoma. Technol Cancer Res Treat. 2023;22:15330338231202893.","journal-title":"Technol Cancer Res Treat"},{"key":"4328_CR11","doi-asserted-by":"publisher","unstructured":"Nishida A, Andoh A. The Role of Inflammation in Cancer: Mechanisms of Tumor Initiation, Progression, and Metastasis. Cells. 2025;14(7). https:\/\/doi.org\/10.3390\/cells14070488.","DOI":"10.3390\/cells14070488"},{"issue":"3","key":"4328_CR12","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","volume":"41","author":"KE de Visser","year":"2023","unstructured":"de Visser KE, Joyce JA. The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth. Cancer Cell. 2023;41(3):374\u2013403.","journal-title":"Cancer Cell"},{"issue":"1","key":"4328_CR13","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/cac2.12613","volume":"45","author":"J Yao","year":"2025","unstructured":"Yao J, Ji L, Wang G, Ding J. Effect of neutrophils on tumor immunity and immunotherapy resistance with underlying mechanisms. Cancer Commun (Lond). 2025;45(1):15\u201342.","journal-title":"Cancer Commun (Lond)"},{"issue":"3","key":"4328_CR14","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/s41416-022-02119-4","volume":"128","author":"K Brummel","year":"2023","unstructured":"Brummel K, Eerkens AL, de Bruyn M, Nijman HW. Tumour-infiltrating lymphocytes: from prognosis to treatment selection. Br J Cancer. 2023;128(3):451\u20138.","journal-title":"Br J Cancer"},{"issue":"23","key":"4328_CR15","doi-asserted-by":"publisher","first-page":"3192","DOI":"10.1182\/blood.2019004119","volume":"137","author":"S Lazar","year":"2021","unstructured":"Lazar S, Goldfinger LE. Platelets and extracellular vesicles and their cross talk with cancer. Blood. 2021;137(23):3192\u2013200.","journal-title":"Blood"},{"key":"4328_CR16","doi-asserted-by":"publisher","unstructured":"Erdem GU, Topuz OV, Acar E, Kapagan T, Yetim E, Ozmen A, Gurocak S, Usul G, Yuksel S, Yardimci AH. Predicting complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: The role of baseline volumetric 18F-FDG PET\/CT parameters and inflammatory markers. Revista Espa\u00f1ola de Med Nuclear e Imagen Mol (English Edition). 2025;500113. https:\/\/doi.org\/10.1016\/j.remn.2025.500113.","DOI":"10.1016\/j.remn.2025.500113"},{"key":"4328_CR17","doi-asserted-by":"publisher","unstructured":"Uyar GC, Ba\u015faran BN, Ba\u015fkurt K, Ye\u015filba\u015f E, \u00d6zkan E, Y\u00fccel KB, Alt\u0131nba\u015f M, Evrimler \u015e, \u00d6ks\u00fczo\u011flu \u00d6B\u00c7, S\u00fctc\u00fco\u011flu O. Predicting Pathologic Response in Locally Advanced Rectal Cancer Using Inflammatory, Nutritional, and Sarcopenia-Based Markers: A Regression and AI-Based Analysis (CINR-AI Study). Clin Colorectal Cancer. 2025. https:\/\/doi.org\/10.1016\/j.clcc.2025.10.002.","DOI":"10.1016\/j.clcc.2025.10.002"},{"key":"4328_CR18","doi-asserted-by":"publisher","first-page":"1483065","DOI":"10.3389\/fonc.2025.1483065","volume":"15","author":"L Zhou","year":"2025","unstructured":"Zhou L, Cao G, Shi L, Fei C, Lao W. Risk factors of pathologic complete response for neoadjuvant chemoradiotherapy in locally advanced rectal cancer. Front Oncol. 2025;15:1483065.","journal-title":"Front Oncol"},{"key":"4328_CR19","doi-asserted-by":"publisher","first-page":"100579","DOI":"10.1016\/j.ctro.2023.100579","volume":"39","author":"G Chiloiro","year":"2023","unstructured":"Chiloiro G, Romano A, Mariani S, Macchia G, Giannarelli D, Caravatta L, Franco P, Boldrini L, Arcelli A, Bacigalupo A. Predictive and prognostic value of inflammatory markers in locally advanced rectal cancer (PILLAR)\u2013A multicentric analysis by the Italian Association of Radiotherapy and Clinical Oncology (AIRO) Gastrointestinal Study Group. Clin translational radiation Oncol. 2023;39:100579.","journal-title":"Clin translational radiation Oncol"},{"key":"4328_CR20","doi-asserted-by":"crossref","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. bmj 2021, 372.","DOI":"10.1136\/bmj.n71"},{"key":"4328_CR21","unstructured":"Wells GA, Shea B, O\u2019Connell D, Peterson J, Welch V, Losos M, Tugwell P. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2000. https:\/\/ohri.ca\/en\/who-we-are\/core-facilities-and-platforms\/ottawa-methods-centre\/newcastle-ottawa-scale."},{"key":"4328_CR22","doi-asserted-by":"publisher","unstructured":"Sterne JA, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I, Cates CJ, Cheng H-Y, Corbett MS, Eldridge SM. RoB 2: a revised tool for assessing risk of bias in randomised trials. bmj. 2019;366. https:\/\/doi.org\/10.1136\/bmj.l4898.","DOI":"10.1136\/bmj.l4898"},{"key":"4328_CR23","doi-asserted-by":"publisher","first-page":"998588","DOI":"10.3389\/fpubh.2023.998588","volume":"11","author":"Y Xun","year":"2023","unstructured":"Xun Y, Guo Q, Ren M, Liu Y, Sun Y, Wu S, Lan H, Zhang J, Liu H, Wang J. Characteristics of the sources, evaluation, and grading of the certainty of evidence in systematic reviews in public health: A methodological study. Front Public Health. 2023;11:998588.","journal-title":"Front Public Health"},{"key":"4328_CR24","doi-asserted-by":"publisher","first-page":"1242193","DOI":"10.3389\/fonc.2023.1242193","volume":"13","author":"J Yang","year":"2023","unstructured":"Yang J, Deng Q, Chen Z, Chen Y, Fu Z. Body composition parameters combined with blood biomarkers and magnetic resonance imaging predict responses to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. Front Oncol. 2023;13:1242193.","journal-title":"Front Oncol"},{"issue":"6","key":"4328_CR25","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.4251\/wjgo.v16.i6.2520","volume":"16","author":"YJ Xu","year":"2024","unstructured":"Xu YJ, Tao D, Qin SB, Xu XY, Yang KW, Xing ZX, Zhou JY, Jiao Y, Wang LL. Prediction of pathological complete response and prognosis in locally advanced rectal cancer. World J Gastrointest Oncol. 2024;16(6):2520\u201330.","journal-title":"World J Gastrointest Oncol"},{"issue":"null","key":"4328_CR26","doi-asserted-by":"publisher","first-page":"701","DOI":"10.2147\/CMAR.S150622","volume":"9","author":"B Xiao","year":"2017","unstructured":"Xiao B, Peng J, Zhang R, Xu J, Wang Y, Fang Y, Lin J, Pan Z, Wu X. Density of CD8\u2009+\u2009lymphocytes in biopsy samples combined with the circulating lymphocyte ratio predicts pathologic complete response to chemoradiotherapy for rectal cancer. Cancer Manage Res. 2017;9(null):701\u20138.","journal-title":"Cancer Manage Res"},{"issue":"1","key":"4328_CR27","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.jons.2017.12.004","volume":"4","author":"Y Bozkaya","year":"2018","unstructured":"Bozkaya Y, \u00d6zdemir NY, Erdem GU, G\u00fcner EK, \u00dcr\u00fcn Y, Demirci NS, Yaz\u0131c\u0131 O, K\u00f6stek O, Zengin N. Clinical predictive factors associated with pathologic complete response in locally advanced rectal cancer. J Oncological Sci. 2018;4(1):5\u201310.","journal-title":"J Oncological Sci"},{"issue":"3","key":"4328_CR28","doi-asserted-by":"publisher","first-page":"253","DOI":"10.3393\/ac.2021.00633.0090","volume":"38","author":"SH An","year":"2022","unstructured":"An SH, Kim IY. Can pretreatment platelet-to-lymphocyte and neutrophil-to-lymphocyte ratios predict long-term oncologic outcomes after preoperative chemoradiation followed by surgery for locally advanced rectal cancer? Annals coloproctology. 2022;38(3):253.","journal-title":"Annals coloproctology"},{"issue":"1","key":"4328_CR29","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1186\/s12885-019-5892-x","volume":"19","author":"S Dudani","year":"2019","unstructured":"Dudani S, Marginean H, Tang PA, Monzon JG, Raissouni S, Asmis TR, Goodwin RA, Gotfrit J, Cheung WY, Vickers MM. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictive and prognostic markers in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiation. BMC Cancer. 2019;19(1):664.","journal-title":"BMC Cancer"},{"key":"4328_CR30","doi-asserted-by":"publisher","unstructured":"Karakaya S, Karada\u011f \u0130, Y\u0131lmaz ME, \u00d6ks\u00fczo\u011flu \u00d6B\u00c7. High neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and low lymphocyte levels are correlated with worse pathological complete response rates. Cureus 2022;14(3). https:\/\/doi.org\/10.7759\/cureus.22972.","DOI":"10.7759\/cureus.22972"},{"issue":"3","key":"4328_CR31","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.21873\/anticanres.11470","volume":"37","author":"IH Lee","year":"2017","unstructured":"Lee IH, Hwang S, Lee SJ, Kang BW, Baek D, Kim HJ, Park SY, Park JS, Choi GS, Kim JC. Systemic inflammatory response after preoperative chemoradiotherapy can affect oncologic outcomes in locally advanced rectal cancer. Anticancer Res. 2017;37(3):1459\u201365.","journal-title":"Anticancer Res"},{"issue":"2","key":"4328_CR32","doi-asserted-by":"publisher","first-page":"100","DOI":"10.3393\/ac.2018.10.01","volume":"35","author":"BH Jeon","year":"2019","unstructured":"Jeon BH, Shin US, Moon SM, Choi JI, Kim M-S, Kim KH, Sung S-J. Neutrophil to lymphocyte ratio: a predictive marker for treatment outcomes in patients with rectal cancer who underwent neoadjuvant chemoradiation followed by surgery. Annals Coloproctology. 2019;35(2):100.","journal-title":"Annals Coloproctology"},{"key":"4328_CR33","doi-asserted-by":"publisher","first-page":"e943750","DOI":"10.12659\/MSM.943750","volume":"30","author":"M Karaca","year":"2024","unstructured":"Karaca M, Salim E, Alemdar MS, Karaca \u00d6D, Ar\u0131c\u0131 M\u00d6. Prognostic significance of Neutrophil-to-Lymphocyte ratio in predicting complete pathological response in rectal cancer patients receiving neoadjuvant chemoradiotherapy. Med Sci Monitor: Int Med J Experimental Clin Res. 2024;30:e943750\u2013943751.","journal-title":"Med Sci Monitor: Int Med J Experimental Clin Res"},{"issue":"44","key":"4328_CR34","doi-asserted-by":"publisher","first-page":"7022","DOI":"10.3748\/wjg.v26.i44.7022","volume":"26","author":"C Cheong","year":"2020","unstructured":"Cheong C, Shin JS, Suh KW. Prognostic value of changes in serum carcinoembryonic antigen levels for preoperative chemoradiotherapy response in locally advanced rectal cancer. World J Gastroenterol. 2020;26(44):7022.","journal-title":"World J Gastroenterol"},{"issue":"35","key":"4328_CR35","doi-asserted-by":"publisher","first-page":"59757","DOI":"10.18632\/oncotarget.15760","volume":"8","author":"SW Jung","year":"2017","unstructured":"Jung SW, Park IJ, Oh SH, Yeom S-S, Lee JL, Yoon YS, Kim CW, Lim S-B, Lee JB, Yu CS. Association of immunologic markers from complete blood counts with the response to preoperative chemoradiotherapy and prognosis in locally advanced rectal cancer. Oncotarget. 2017;8(35):59757.","journal-title":"Oncotarget"},{"issue":"4","key":"4328_CR36","doi-asserted-by":"publisher","first-page":"708","DOI":"10.3892\/ol.2021.12969","volume":"22","author":"S Kim","year":"2021","unstructured":"Kim S, Joo M, Yeo MK, Cho MJ, Kim JS, Jo EK, Kim JM. Small heterodimer partner as a predictor of neoadjuvant radiochemotherapy response and survival in patients with rectal cancer: A preliminary study. Oncol Lett. 2021;22(4):708.","journal-title":"Oncol Lett"},{"issue":"1","key":"4328_CR37","doi-asserted-by":"publisher","first-page":"118","DOI":"10.3748\/wjg.v25.i1.118","volume":"25","author":"D-L Ren","year":"2019","unstructured":"Ren D-L, Li J, Yu H-C, Peng S-Y, Lin W-D, Wang X-L, Ghoorun RA. Luo Y-X: Nomograms for predicting pathological response to neoadjuvant treatments in patients with rectal cancer. World J Gastroenterol. 2019;25(1):118.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"4328_CR38","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1159\/000348385","volume":"85","author":"M Krauthamer","year":"2013","unstructured":"Krauthamer M, Rouvinov K, Ariad S, Man S, Walfish S, Pinsk I, Sztarker I, Charkovsky T, Lavrenkov K. A study of inflammation-based predictors of tumor response to neoadjuvant chemoradiotherapy for locally advanced rectal cancer. Oncology. 2013;85(1):27\u201332.","journal-title":"Oncology"},{"key":"4328_CR39","doi-asserted-by":"publisher","unstructured":"Mehraj A, Baba AA, Khan B, Khan MA, Wani RA, Parray FQ, Chowdri NA. Predictors of pathological complete response following neoadjuvant chemoradiotherapy for rectal cancer. J Cancer Res Ther 2022;18(2). https:\/\/doi.org\/10.4103\/jcrt.JCRT_1273_20.","DOI":"10.4103\/jcrt.JCRT_1273_20"},{"key":"4328_CR40","doi-asserted-by":"publisher","unstructured":"Soykut EDk, Kemal Y, Odaba\u015fi E, \u015eahi\u0307n N, Ya\u011fiz BK, Yazicio\u011flu IM, Arslan SA, G\u00fcney Y. Pre-Treatment and Post-Treatment Neutrophil-to-Lymphocyte Ratio Predict Pathological Tumor Response and Survival in Rectal Cancer Patients Treated with Neoadjuvant Chemoradiotherapy. Turkish J Oncol. 2022;37(2). https:\/\/doi.org\/10.5505\/tjo.2022.3467.","DOI":"10.5505\/tjo.2022.3467"},{"issue":"4","key":"4328_CR41","first-page":"399","volume":"30","author":"E Eraslan","year":"2021","unstructured":"Eraslan E, Adas YG, Yildiz F, Gulesen AI, Karacin C, Arslan UY. Systemic immune-inflammation index (SII) predicts pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. J Coll Physicians Surg Pak. 2021;30(4):399\u2013404.","journal-title":"J Coll Physicians Surg Pak"},{"issue":"1","key":"4328_CR42","doi-asserted-by":"publisher","first-page":"319","DOI":"10.3892\/ol.2023.13905","volume":"26","author":"F Zhang","year":"2023","unstructured":"Zhang F, Yu D, Yang J, Zhai M, Li L, Zhao L, Wang J, Zhang T, Lin Z. Pretreatment high cholesterol and low neutrophils predict complete pathological response after neoadjuvant short\u2013course radiotherapy followed by chemotherapy and immunotherapy in locally advanced rectal cancer. Oncol Lett. 2023;26(1):319.","journal-title":"Oncol Lett"},{"issue":"6","key":"4328_CR43","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1080\/07357907.2024.2366912","volume":"42","author":"W-N Yang","year":"2024","unstructured":"Yang W-N, Li X-M, Li C-F, Chen C, Feng Y, Dai N, Yang Y-X, Li M-X, Li C-X, Qian C-Y. Gustative Roussy Immune Score is a Predictor for Major Pathological Response in Rectal Cancer: A Result from the Preoperative Intraarterial Chemoembolization Combined with Radiotherapy (PCAR) Study. Cancer Invest. 2024;42(6):527\u201337.","journal-title":"Cancer Invest"},{"issue":"28","key":"4328_CR44","doi-asserted-by":"publisher","first-page":"3233","DOI":"10.2217\/fon-2019-0389","volume":"15","author":"A Li","year":"2019","unstructured":"Li A, He K, Guo D, Liu C, Wang D, Mu X, Yu J. Pretreatment blood biomarkers predict pathologic responses to neo-CRT in patients with locally advanced rectal cancer. Future Oncol. 2019;15(28):3233\u201342.","journal-title":"Future Oncol"},{"key":"4328_CR45","doi-asserted-by":"publisher","first-page":"850774","DOI":"10.3389\/fonc.2022.850774","volume":"12","author":"Y Mao","year":"2022","unstructured":"Mao Y, Pei Q, Fu Y, Liu H, Chen C, Li H, Gong G, Yin H, Pang P, Lin H, et al. Pre-Treatment Computed Tomography Radiomics for Predicting the Response to Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer: A Retrospective Study. Front Oncol. 2022;12:850774.","journal-title":"Front Oncol"},{"key":"4328_CR46","doi-asserted-by":"publisher","first-page":"1658571","DOI":"10.3389\/fimmu.2025.1658571","volume":"16","author":"Z Zhao","year":"2025","unstructured":"Zhao Z, Xu H, Ma B, Dong C. Prognostic value of platelet to lymphocyte ratio (PLR) in breast cancer patients receiving neoadjuvant therapy: a systematic review and meta-analysis. Front Immunol. 2025;16:1658571.","journal-title":"Front Immunol"},{"issue":"6","key":"4328_CR47","doi-asserted-by":"publisher","first-page":"e675","DOI":"10.1016\/j.clbc.2020.05.008","volume":"20","author":"C Cullinane","year":"2020","unstructured":"Cullinane C, Creavin B, O\u2019Leary DP, O\u2019Sullivan MJ, Kelly L, Redmond HP, Corrigan MA. Can the Neutrophil to Lymphocyte Ratio Predict Complete Pathologic Response to Neoadjuvant Breast Cancer Treatment? A Systematic Review and Meta-analysis. Clin Breast Cancer. 2020;20(6):e675\u201381.","journal-title":"Clin Breast Cancer"},{"key":"4328_CR48","doi-asserted-by":"publisher","first-page":"1615962","DOI":"10.3389\/fimmu.2025.1615962","volume":"16","author":"L Ma","year":"2025","unstructured":"Ma L, He J, Li P, Ma L, Wang H, Deng Y. Prognostic value of neutrophil to lymphocyte ratio in patients with esophagus cancer receiving neoadjuvant therapy: a systematic review and meta-analysis. Front Immunol. 2025;16:1615962.","journal-title":"Front Immunol"},{"key":"4328_CR49","doi-asserted-by":"publisher","first-page":"1335546","DOI":"10.3389\/fimmu.2023.1335546","volume":"14","author":"F Qu","year":"2023","unstructured":"Qu F, Luo Y, Peng Y, Yu H, Sun L, Liu S, Zeng X. Construction and validation of a prognostic nutritional index-based nomogram for predicting pathological complete response in breast cancer: a two-center study of 1,170 patients. Front Immunol. 2023;14:1335546.","journal-title":"Front Immunol"},{"key":"4328_CR50","doi-asserted-by":"publisher","first-page":"681905","DOI":"10.3389\/fonc.2021.681905","volume":"11","author":"F Qu","year":"2021","unstructured":"Qu F, Li Z, Lai S, Zhong X, Fu X, Huang X, Li Q, Liu S, Li H. Construction and Validation of a Serum Albumin-to-Alkaline Phosphatase Ratio-Based Nomogram for Predicting Pathological Complete Response in Breast Cancer. Front Oncol. 2021;11:681905.","journal-title":"Front Oncol"},{"key":"4328_CR51","doi-asserted-by":"publisher","unstructured":"Hou R, Wu X, Wang C, Fan H, Zhang Y, Wu H, Wang H, Ding J, Jiang H, Xu J. Tumor\u2013associated neutrophils: Critical regulators in cancer progression and therapeutic resistance (Review). Int J Oncol. 2025;66(4). https:\/\/doi.org\/10.3892\/ijo.2025.5734.","DOI":"10.3892\/ijo.2025.5734"},{"key":"4328_CR52","doi-asserted-by":"publisher","unstructured":"Ozel I, Duerig I, Domnich M, Lang S, Pylaeva E, Jablonska J. The Good, the Bad, and the Ugly: Neutrophils, Angiogenesis, and Cancer. Cancers (Basel). 2022;14(3). https:\/\/doi.org\/10.3390\/cancers14030536.","DOI":"10.3390\/cancers14030536"},{"issue":"1","key":"4328_CR53","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/s41392-025-02242-7","volume":"10","author":"Y Zhou","year":"2025","unstructured":"Zhou Y, Shen G, Zhou X, Li J. Therapeutic potential of tumor-associated neutrophils: dual role and phenotypic plasticity. Signal Transduct Target Ther. 2025;10(1):178.","journal-title":"Signal Transduct Target Ther"},{"key":"4328_CR54","first-page":"639","volume":"17","author":"EI Obeagu","year":"2025","unstructured":"Obeagu EI. N2 Neutrophils and Tumor Progression in Breast Cancer: Molecular Pathways and Implications. Breast Cancer (Dove Med Press). 2025;17:639\u201351.","journal-title":"Breast Cancer (Dove Med Press)"},{"issue":"1","key":"4328_CR55","doi-asserted-by":"publisher","first-page":"30518","DOI":"10.1038\/s41598-025-14720-7","volume":"15","author":"J Mai","year":"2025","unstructured":"Mai J, Yang L, Chen Y, Zeng X, Xie H, Liu X. Prediction of CD8(+) T cell infiltration in the tumor microenvironment of HGSOC patients. Sci Rep. 2025;15(1):30518.","journal-title":"Sci Rep"},{"issue":"5","key":"4328_CR56","doi-asserted-by":"publisher","first-page":"e350","DOI":"10.1002\/mco2.350","volume":"4","author":"K Liao","year":"2023","unstructured":"Liao K, Zhang X, Liu J, Teng F, He Y, Cheng J, Yang Q, Zhang W, Xie Y, Guo D, et al. The role of platelets in the regulation of tumor growth and metastasis: the mechanisms and targeted therapy. MedComm (2020). 2023;4(5):e350.","journal-title":"MedComm (2020)"},{"issue":"3","key":"4328_CR57","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.ygyno.2019.02.026","volume":"153","author":"Y Guo","year":"2019","unstructured":"Guo Y, Cui W, Pei Y, Xu D. Platelets promote invasion and induce epithelial to mesenchymal transition in ovarian cancer cells by TGF-\u03b2 signaling pathway. Gynecol Oncol. 2019;153(3):639\u201350.","journal-title":"Gynecol Oncol"},{"key":"4328_CR58","doi-asserted-by":"publisher","unstructured":"Zhang L, Yuan Y, Deng Y, Wang L, Chen F. Platelet\u2013circulating tumor cell crosstalk: A pivotal target in cancer diagnosis and therapy (Review). Oncol Rep. 2026;55(1). https:\/\/doi.org\/10.3892\/or.2025.9007.","DOI":"10.3892\/or.2025.9007"},{"issue":"5","key":"4328_CR59","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1097\/MS9.0000000000001297","volume":"86","author":"M Morais","year":"2024","unstructured":"Morais M, Fonseca T, Machado-Neves R, Honavar M, Coelho AR, Lopes J, Guerreiro E, Carneiro S. Prognostic value of neutrophil-to-lymphocyte ratio (NLR) and platelet-neutrophil (PN) index in locally advanced rectal cancer patients: a retrospective cohort study. Ann Med Surg (Lond). 2024;86(5):2474\u201380.","journal-title":"Ann Med Surg (Lond)"},{"key":"4328_CR60","doi-asserted-by":"publisher","unstructured":"To NH, Gabelle-Flandin I, Luong TMH, Loganadane G, Ouidir N, Boukhobza C, Grellier N, Verry C, Thiolat A, Cohen JL et al. Pathologic Response to Neoadjuvant Sequential Chemoradiation Therapy in Locally Advanced Breast Cancer: Preliminary, Translational Results from the French Neo-APBI-01 Trial. Cancers (Basel). 2023;15(7). https:\/\/doi.org\/10.3390\/cancers15072030.","DOI":"10.3390\/cancers15072030"},{"issue":"16suppl","key":"4328_CR61","first-page":"e15621","volume":"43","author":"J Peng","year":"2025","unstructured":"Peng J, Zhou C, Qiu M, Li W, Wang Q, Liu M, Quan T-T, Lu Z-H, Wu X, Li L, et al. Phase II trial of anti PD-1 monoclonal antibody and FOLFOXIRI combined with long-course radiotherapy as the total neoadjuvant treatment for proficient mismatch repair, locally advanced, low rectal cancer (PANFORTE). J Clin Oncol. 2025;43(16suppl):e15621\u201315621.","journal-title":"J Clin Oncol"},{"key":"4328_CR62","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.jss.2017.11.072","volume":"224","author":"WH Ward","year":"2018","unstructured":"Ward WH, Sigurdson ER, Esposito AC, Ruth KJ, Manstein SM, Sorenson EC, Wernick BD, Farma JM. Pathologic response following treatment for locally advanced rectal cancer: Does location matter? J Surg Res. 2018;224:215\u201321.","journal-title":"J Surg Res"},{"issue":"3","key":"4328_CR63","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1093\/gastro\/goz073","volume":"8","author":"J-W Zhang","year":"2020","unstructured":"Zhang J-W, Cai Y, Xie X-Y, Hu H-B, Ling J-Y, Wu Z-H, Lan P, Wu X-J, Huang M-J, Wang H, et al. Nomogram for predicting pathological complete response and tumor downstaging in patients with locally advanced rectal cancer on the basis of a randomized clinical trial. Gastroenterol Rep. 2020;8(3):234\u201341.","journal-title":"Gastroenterol Rep"},{"key":"4328_CR64","doi-asserted-by":"publisher","first-page":"1120684","DOI":"10.3389\/fimmu.2023.1120684","volume":"14","author":"J Zhu","year":"2023","unstructured":"Zhu J, Lian J, Xu B, Pang X, Ji S, Zhao Y, Lu H. Neoadjuvant immunotherapy for colorectal cancer: Right regimens, right patients, right directions? Front Immunol. 2023;14:1120684.","journal-title":"Front Immunol"},{"key":"4328_CR65","doi-asserted-by":"publisher","first-page":"1719642","DOI":"10.3389\/fonc.2025.1719642","volume":"15","author":"B Farooq","year":"2025","unstructured":"Farooq B, Li X, Xiao S, Liu X. Neoadjuvant therapy for pMMR\/MSS locally advanced rectal cancer in the immunotherapy era: current landscape and future perspectives. Front Oncol. 2025;15:1719642.","journal-title":"Front Oncol"},{"key":"4328_CR66","doi-asserted-by":"publisher","unstructured":"Li M, Dieckmann T, Herrle F, Hofheinz RD, Hielscher T, Hertel A, Schweitzer S, Hetjens S, Betge J, Belle S et al. Structured Magnetic Resonance Imaging Assessment Improves Diagnosis of Pathological Complete Response in Rectal Cancer after Neoadjuvant Chemoradiation. Oncol Res Treat 2025;1\u201313. https:\/\/doi.org\/10.1159\/000548042.","DOI":"10.1159\/000548042"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-026-04328-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04328-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04328-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T11:26:50Z","timestamp":1778671610000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12957-026-04328-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,2]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4328"],"URL":"https:\/\/doi.org\/10.1186\/s12957-026-04328-0","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,2]]},"assertion":[{"value":"27 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This study is a systematic review and meta-analysis of published, de-identified data and did not involve direct contact with human participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"204"}}